4 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sharon Walsh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Behavioral Effects of Opioids and Alcohol Alcohol, Opioid Agonist - Opioid Use, Alcohol Drinking | Phase 1 | Completed | Sharon Walsh | 11 | 2021-03-24 | 2025-11-20 |
| Prescription Medication Interactions Opioid Agonist, Sedatives - Opioid Use, Sedative Use | Phase 1 | Completed | Sharon Walsh | 11 | 2019-03-25 | 2025-10-20 |
| Aprepitant Effects on Oxycodone Response Aprepitant 0mg, Aprepitant 40mg, Aprepitant 200mg - Narcotic Abuse | Not applicable | Completed | Sharon Walsh | 9 | 2009-10-01 | 2017-09-01 |
| Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial atomoxetine, placebo - Substance Abuse | Phase 2 | Completed | Sharon Walsh | 50 | 2007-07-01 | 2017-08-31 |
Alcohol Drinking (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
Analgesics, Opioid (2) · Aprepitant (1) · Atomoxetine Hydrochloride (1) · Ethanol (1) · Hypnotics and Sedatives (1) · Oxycodone (1)
United States (4)
Sharon L Walsh, Ph.D. (3) · Sharon L Walsh, PhD (1)
R01DA016718 (2), R01DA022191 (1), R01DA027031 (1)